“Probable Reversible Encephalopathy with Ceftazidime/Avibactam and Aztreonam: A Case Report” (2026) Asian Journal of Pharmaceutical and Health Sciences, 16(2), pp. 3283–3287. doi:10.5530/ajphs.2026.16.94.